ABBVIE, INC. lobbying for ABBVIE INC.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Expenses

$1,160,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 5

Commerce, Dept of (DOC)
HOUSE OF REPRESENTATIVES
SENATE
Treasury, Dept of
U.S. Trade Representative (USTR)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 6

S 1040
Drug Competition Enhancement Act
S 864
HELP Copays Act
HR 5376
Impacts and Outcomes for Health Career Training Act
HR 1328
Supply Chain Security and Growth Act of 2025
HR 1990
American Innovation and R&D Competitiveness Act of 2025
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 6

Copyright/Patent/Trademark

S.1040, Drug Competition Enhancement Act Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property

Health Issues

S. 864, HELP Copays Act Drug cost and pricing policy issues Patient affordability issues Issues related to the 340B program

Medicare/Medicaid

Public Law 117-169 (formerly known as H.R. 5376, Inflation Reduction Act) Implementation regarding Medicare Part D drug negotiation program Policy Proposals related to Medicare Part D and patient cost-sharing Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues Issues related to HCV treatment

Taxation/Internal Revenue Code

H.R. 1328, Supply Chain Security and Growth Act of 2025 H.R. 1990, American Innovation and R&D Competitiveness Act of 2025 H.R. 1, One Big Beautiful Bill Act Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation Policy proposals relating to economic activity in Puerto Rico International tax issues, including OECD digital taxation work program

Labor Issues/Antitrust/Workplace

Issues related to antitrust and competition policy

Trade (domestic/foreign)

Issues related to pharmaceutical tariffs